PHYTOCHEMICAL PROFILING AND ANTIBACTERIAL ACTIVITY OF THE NONPOLAR FRACTION OF THE LEAF OF PLUMBAGO ZEYLANICA (LINN.) PLUMBAGINACEAE.
Published In: Journal of Pharmaceutical & Allied Sciences, 2025, v. 22, n. 2. P. 4681 1 of 3
Database: Academic Search Ultimate 2 of 3
Authored By: AIWONEGBE, A. E.; OBU, O. U.; OTOE, A. I.; ODION, E. E. 3 of 3
Abstract
The increasing challenge of antibiotic resistance has necessitated the search for alternative antibacterial agents from natural sources. Plumbago zeylanica L. (Plumbaginaceae), a medicinal plant widely used in African traditional medicine, is known for its antibacterial properties. This study aims to investigate the phytochemical composition and evaluate the antibacterial activity of the non-polar fraction of P. zeylanica leaf. N-hexane fraction was obtained from the hydroalcohol extract following isocratic elution with n-hexane. Phyto-constituents were determined by preliminary phytochemical screening and Gas Chromatography-Mass Spectrometry (GC-MS) analysis. Susceptibility test was achieved by Agar well diffusion protocol, while broth dilution method was used to determine the Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC). Phytochemical screening revealed the following: flavonoids, saponins, terpenoids, alkaloids, and phenolic compounds. GC-MS analysis afforded fifty-seven compounds with naphthalene, decahydro-2-methyl (4.02 %), benzene-1-methyl-3-propyl (4.37 %), naphthalene, decahydro-, trans (4.49%), ethyl, 9,12,15-octadecatrienoate (4.54%), benzene-1,4-diethyl- (4.72%), benzene-1,2,4,5-tetramethyl (4.75%), n-tetracosanol-1 (5.04%), hexadecanoic acid ethyl ester (5.28%) and benzene-1,2,4-trimethyl (6.00%) as the most noticeable. The antibacterial assessment demonstrated selective zones of inhibition against Escherichia coli (13 mm) and Bacillus cereus (17 mm). MIC and MBC against E. coli were 3.8 mg/mL and 15 mg/mL, while for B. cereus, they were 30 mg/mL each. The results indicate that P. zeylanica fraction contains bactericidal compounds particularly against E. coli and B. cereus. [ABSTRACT FROM AUTHOR]
Additional Information
- Source:Journal of Pharmaceutical & Allied Sciences. 2025/04, Vol. 22, Issue 2, p4681
- Document Type:Article
- Subject Area:Health and Medicine
- Publication Date:2025
- ISSN:1596-8499
- Accession Number:186152264
- Copyright Statement:Copyright of Journal of Pharmaceutical & Allied Sciences is the property of University of Nigeria, Department of Pharmaceutics and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Looking to go deeper into this topic? Look for more articles on EBSCOhost.